Qube Research & Technologies (QRT)
SION

Qube Research & Technologies (QRT)’s Sionna Therapeutics SION Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.17M Buy
140,309
+98,067
+232% +$3.92M 0.01% 1532
2026
Q1 		$1.69M Buy
+42,242
New +$1.61M ﹤0.01% 2263

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SION Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Sionna Therapeutics (SION) stake by 232% in Q2 2026, buying an estimated $3.92M and bringing the position to 140,309 shares worth $6.17M. The position accounts for 0.01% of the portfolio, ranked #1532.

Qube Research & Technologies (QRT) first reported a position in SION in Q1 2026 and has held it in 2 quarters since. 146 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • Qube Research & Technologies (QRT) held 140,309 shares of Sionna Therapeutics worth $6.17M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 98,067 Sionna Therapeutics shares in Q2 2026, an estimated $3.92M.
  • Sionna Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1532 holding.
  • Qube Research & Technologies (QRT) first reported a position in Sionna Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 146 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.